The Spanish Environmental Mutagenesis and Genomics Society (SEMA) invites you to participate in the 51st congress of the European Environmental Mutagenesis and Genomics Society (EEMGS), that will take place with our 27th Scientific Meeting. The congress will be entitled «Back to the sunny seashore of genotoxicology: a dive into new developments and applications» and held in our beautiful city of Málaga (Spain) from May 15th to 18th, 2023.
The EEMGS/SEMA 2023 congress will be accompanied by a satellite workshop organised by HESI and focused on «Quantitative Interpretation of Genetic Toxicity Dose-response Data for Risk Assessment and Reg Decision-making«, that will take place on May 15th, just before the beginning of the congress.
After the many difficulties generated by the COVID-19 pandemic, the scientific committee is working hard to meet the challenge of returning to the normality of face-to-face meetings and the richness of direct contact with scientists of multiple nationalities. We are designing what we hope will be a very attractive scientific programme, both for academia and industry, that includes recent findings and current advances in mutagenesis and environmental genomics with a special dedication to applied and regulatory genotoxicity testing.
Join us in Málaga for a memorable and inspiring congress!
SEMA Executive Committee
- María Teresa Roldán-Arjona
University of Córdoba, SPAIN - Luisa María Sierra Zapico
University of Oviedo, SPAIN - Alba Hernández Bonilla
Autonomous University of Barcelona, SPAIN - Óscar Herrero Felipe
Spanish National University for Distance Education, SPAIN
- Amaya Azqueta Oscoz
University of Navarra, SPAIN - Blanca Laffon Lage
University of A Coruña, SPAIN - Antonio Guzmán Cano
Alexion Pharmaceuticals, Inc., SPAIN - Isabel Gaivão
University of Trás-os-Montes e Alto Douro, PORTUGAL
- Amaya Azqueta Oscoz
University of Navarra, SPAIN - Stefano Bonassi
San Raffaele University, ITALY - Roland Frötschl
Federal Institute for Drugs and Medical Devices, GERMANY - Isabel Gaivão
University of Trás-os-Montes e Alto Douro, PORTUGAL - Goran Gajski
Institute for Medical Research and Occupational Health, CROATIA - Marko Gerić
Institute for Medical Research and Occupational Health, CROATIA - Antonio Guzmán Cano
Alexion Pharmaceuticals, Inc., SPAIN - Alba Hernández Bonilla
Autonomous University of Barcelona, SPAIN - Óscar Herrero Felipe
Spanish National University for Distance Education, SPAIN - Awadhesh Jha
University of Plymouth, UK - George Johnson
Swansea University, UK - Blanca Laffon Lage
University of A Coruña, SPAIN
- Anthony Lynch
GlaxoSmithKline Pharma GmbH, UK - Ricard Marcos
Autonomous University of Barcelona, SPAIN - Hans-Joerg Martus
Novartis, SWITZERLAND - Birgit Mertens
Belgian Institute for Health, BELGIUM - Vanessa Moraes de Andrade
Universidade do Extremo Sul Catarinense, BRAZIL - Guillermo Repetto
Pablo de Olavide University, SPAIN - María Teresa Roldán-Arjona
University of Córdoba, SPAIN - Julen Sanz-Serrano
Vrije Universiteit Brussel, BELGIUM - Luisa María Sierra Zapico
University of Oviedo, SPAIN - Vanessa Valdiglesias García
University of A Coruña, SPAIN - Andreas Zeller
Roche, SWITZERLAND
HESI Workshop
Quantitative Interpretation of Genetic Toxicity Dose-response Data for Risk Assessment and Regulatory Decision-making – State of the Science, Applications, and Persistent Challenges
Andreas Zeller (Roche), George Johnson (Swansea University), Paul White (Health Canada)
on behalf of the HESI GTTC
HUMN Workshop
The buccal micronucleus (MN) cytome assay – New Horizons for its implementation in human biomonitoring and clinical studies
Michael Fenech (University of South Australia), Siegfried Knasmueller (Medical University of Vienna Institute of Cancer Research), Stefano Bonassi (San Raffaele University)
Our 29 hotels have been adapted for people with disabilities and have been awarded the universal accessibility certification (UNE 170001-2) and the QSostenible certificate that guarantees the sustainability of our buildings.
We are the first Spanish company to receive the Ethics Award from the United Nations World Tourism Organization (UNWTO) for our work in the field of accessible tourism.
